Lupin 2024

U.S. Pharmacopeia

Health care outlook 2024: Ronald Piervincenzi, CEO, U.S. Pharmacopeia

Health care outlook 2024: Ronald Piervincenzi, CEO, U.S. Pharmacopeia

In the second of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The past year was significant for the pharmaceutical industry, as we witnessed major milestones and celebrated advancements in innovation. We saw an official end to the COVID-19 pandemic public health emergency and unlocked the potential

Pharmacy groups advocate USP standards for biologics

Pharmacy groups advocate USP standards for biologics

WASHINGTON — A coalition of pharmacy industry organizations has asked congressional leaders to weigh proposals that would free certain biologic drugs from adherence to U.S. Pharmacopeia (USP) standards. This week, the American Pharmacists Association (APhA) and eight other groups sent a letter to the chairman and ranking members of key House and Senate committees expressing

PP_1170x120_10-25-21